retatrutide type 2 diabetes trial 2024 This data from Phase 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce 💉 A triple-action once-weekly injection

Approved GLP-1-based therapies can still have side effects, contraindications, and monitoring needs

GLP-1 agonist weight loss medications like Wegovy and Saxenda have a high probability of causing thyroid cancer based on available evidence These medications were originally designed for diabetes and then repurposed for weight loss, which means the long-term thyroid safety data is still limited The potential benefits of GLP-1 agonists for weight loss must be carefully weighed against the significant risk of developing thyroid cancer If you're considering these medications, have a detailed conversation with your doctor about your personal thyroid cancer risk versus the weight loss benefits Do the most popular weight loss medications of our time like Wegovy and Saxenda cause thyroid cancer

Theyll provide better and safer guidelines regarding Semaglutide administration and dosage

Global Health Observatory data repository: Life tables by country (Spain)

Batch certificates are available for every unit produced

The science keeps moving forward, and these new updates keep coming